Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
NCT02436057 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 255
Last updated 2016-01-15
Summary
Through a four-year grant awarded to the University of California at Los Angeles in 2009, Dr. Brennan Spiegel served as a principal investigator (PI) for a project to develop and initially validate a bank of items to assess gastrointestinal (GI) symptoms for the National Institutes of Health's (NIH's) Patient Reported Outcomes Measurement Information System (PROMIS). By the end of the grant period in July 2013, the project team had successfully developed and initially validated eight scales measuring the most common GI symptoms.
Afterwards, Dr. Spiegel's PROMIS team joined forces with the UCLA Computing Technology Research Laboratory (CTRL) and the University of Michigan Center for Healthcare Communication Research to develop the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) algorithm which is delivered via My GI Health, an open--source Internet based patient-provider portal (P3) designed to enhance the delivery of GI health care (www.MyGIHealth.org). Through My GI Health and AEGIS, patients are able to complete PROMIS GI symptom measures and provide additional information about their GI symptoms and histories from computers, tablets or smart phones without the constraints of physical locale. This information is condensed into a GI PROMIS scores report and initial GI history that patients' providers can review prior to or concurrent with seeing the patient. The report, which can be incorporated into the electronic health record (EHR), helps busy clinicians to quickly understand the patient's complaints, document their symptoms and GI history, and leaves more time for conversation with the patient.
Beyond focusing their interaction, My GI Health also supports both the clinician and patient with an individualized "educational prescription" which guides the patient through a library of multi-media educational materials on GI symptoms, conditions, and treatments also contained within the website. The prescription is initially created by the website based on each patient's unique GI PROMIS "fingerprint", and can be modified by the provider based on their interaction with the patient. The clinician and patient can also access the PROMIS-tailored education in the exam room to jointly review pertinent materials, including animations of normal and abnormal GI functions, further reinforcing the patients' educational experiences around the PROMIS symptoms.
The aim of this current study is to validate the use of GI PROMIS in clinical practice by conducting a pragmatic clinical trial (PCT) comparing delivery of GI PROMIS on a novel e--platform vs. usual care.
Conditions
- Abdominal Pain
- Deglutition Disorders
- Fecal Incontinence
- Nausea
- Diarrhea
- Constipation
- Gastroesophageal Reflux
Interventions
- OTHER
-
AEGIS (Automated Evaluation of Gastrointestinal Symptoms)
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH -
University of California, Los Angeles
collaborator OTHER -
VA Medical Center-West Los Angeles
collaborator FED - collaborator OTHER
-
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
collaborator NIH -
Cedars-Sinai Medical Center
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-07-31
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
Countries
- United States
Study Locations
More Related Trials
-
CEGIR 7807: Validation of Online Cohort of EGID Patients Enrolled in RDCRN CEGIR Contact Registry
NCT03382678 ·Status: COMPLETED
-
Can We Predict Who Has Gastroesophageal Reflux Disease (GERD)?
NCT01204931 ·Status: COMPLETED
-
Precision Approach to PPI Therapy in Gastroesophageal Reflux Disease
NCT03619811 ·Status: COMPLETED ·Phase: NA
-
Decision Aid for Gastroesophageal Reflux Disease Management
NCT01641887 ·Status: UNKNOWN
-
Open, Randomised, Multi-center Study of on Demand Versus Continuous Esomeprazole Treatment in Patient With GERD
NCT02670642 ·Status: COMPLETED ·Phase: PHASE3
-
Gastroesophageal Reflux Disease Prospective Registry
NCT02479438 ·Status: TERMINATED
-
Diagnostic Tests in Supra-Esophageal Gastroesophageal Reflux Disease (SE-GERD)
NCT05695846 ·Status: WITHDRAWN ·Phase: NA
-
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
NCT01382563 ·Status: COMPLETED
-
Diagnostic Yield of Post PRandial Esophageal High Resolution Impedance Manometry in Patients With Gastro-Esophageal Reflux Disease Symptoms Resistant to Proton Pump Inhibitor Therapy
NCT03596476 ·Status: RECRUITING ·Phase: NA
-
Mechanisms Preventing Pharyngeal Reflux
NCT05696184 ·Status: RECRUITING ·Phase: NA
-
Effectiveness of Physiologic Testing in PPI Non-Responders
NCT03202537 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms
NCT00703534 ·Status: COMPLETED ·Phase: PHASE2
-
The Difference of Reflux Pattern Between the Patients Who Have Postprandial Reflux Symptoms
NCT02154659 ·Status: COMPLETED ·Phase: NA
-
Symptom Assessment in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) or enGERD (Endoscopic-negative GERD) After Treatment With Pantoprazole (BY1023/M3-343)
NCT00336219 ·Status: COMPLETED ·Phase: PHASE3
-
Confocal Endomicroscopy for Permeability of Esophageal Wall in Refractory Gastroesophageal Reflux Disease (GERD)
NCT03228407 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Acid Reflux at Two Levels in the Esophagus Using the BRAVO Capsule
NCT00579410 ·Status: COMPLETED
-
Prospective Evaluation of PH-impedance Tracings According to the Wingate Consensus, and Influence on GERD Classification According to the Lyon Consensus
NCT06084572 ·Status: RECRUITING
-
Correlates of GERD Symptom Severity
NCT03020550 ·Status: COMPLETED
-
Development of Applications of the Bravo® pH Monitoring System and Evaluation of Its Performance
NCT01503476 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating Medication Adherence of Patients With Gastroesophageal Reflux Disease With Support of the Smartphone Application GERDCare
NCT07125521 ·Status: RECRUITING ·Phase: NA
-
Assessment of Esophageal Epithelium Integrity With Mucosal Impedance
NCT02318862 ·Status: COMPLETED ·Phase: NA
-
Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of GERD
NCT00524355 ·Status: COMPLETED
-
Symptom Assessment for Patients With Gastro-esophageal Reflux Disease Receiving Helicobacter Pylori Eradication
NCT02934152 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluating Medication Adherence of Patients With Gastroesophageal Reflux Disease With Support of Smartphone Application GERDCare
NCT07127276 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Tract Symptoms in Egypt
NCT01635959 ·Status: COMPLETED